Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and β-endorphin-(10–16), like antidepressants, antagonize melatonin-induced behavioural changes in rats
- 1 September 1995
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 284 (3) , 327-330
- https://doi.org/10.1016/0014-2999(95)00473-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Improvement in major depression after low subcutaneous doses of MIF-1Journal of Affective Disorders, 1994
- Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugsEuropean Journal of Pharmacology, 1992
- MIF-1 is active in a chronic stress animal model of depressionPharmacology Biochemistry and Behavior, 1989
- Blockade of brain dopamine receptors antagonizes the anti-immobility effect of MIF-1 and Tyr-MIF-1 in ratsEuropean Journal of Pharmacology, 1988
- β-endorphin-(10–16) antagonizes behavioral responses elicited by melatonin following injection into the nucleus accumbens of ratsLife Sciences, 1985
- Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of ratsNeuropharmacology, 1985
- Neuropeptides and social behavior of rats tested in dyadic encountersNeuropeptides, 1984
- Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analoguesPeptides, 1984
- Modulation of substantia nigra self-stimulation by neuropeptides related to neurohypophyseal hormonesBrain Research, 1979
- Melanocyte-Stimulating Hormone-Release Inhibiting Hormone as an AntidepressantArchives of General Psychiatry, 1974